Detalhe da pesquisa
1.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 204(2): 525-533, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905734
2.
Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Langenbecks Arch Surg
; 408(1): 34, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648571